<VariationArchive RecordType="classified" VariationID="16317" VariationName="NM_001002294.3(FMO3):c.192del (p.Glu65fs)" VariationType="Deletion" Accession="VCV000016317" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-07-17" DateCreated="2015-08-15" MostRecentSubmission="2015-08-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="31356" VariationID="16317">
      <GeneList>
        <Gene Symbol="FMO3" FullName="flavin containing dimethylaniline monoxygenase 3" GeneID="2328" HGNC_ID="HGNC:3771" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="171090905" stop="171117819" display_start="171090905" display_stop="171117819" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="171060017" stop="171086958" display_start="171060017" display_stop="171086958" Strand="+" />
          </Location>
          <OMIM>136132</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001002294.3(FMO3):c.192del (p.Glu65fs)</Name>
      <CanonicalSPDI>NC_000001.11:171103841:AAA:AA</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>1q24.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="171103842" stop="171103842" display_start="171103842" display_stop="171103842" variantLength="1" positionVCF="171103841" referenceAlleleVCF="CA" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="171072983" stop="171072983" display_start="171072983" display_stop="171072983" variantLength="1" positionVCF="171072982" referenceAlleleVCF="CA" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>E45fs</ProteinChange>
      <ProteinChange>E65fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.171072985del" Assembly="GRCh37">
            <Expression>NC_000001.10:g.171072985del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.171103844del" Assembly="GRCh38">
            <Expression>NC_000001.11:g.171103844del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012690.1" sequenceAccession="NG_012690" sequenceVersion="1" change="g.17968del">
            <Expression>NG_012690.1:g.17968del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001002294.3" sequenceAccession="NM_001002294" sequenceVersion="3" change="c.192del" MANESelect="true">
            <Expression>NM_001002294.3:c.192del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001002294.1" sequenceAccession="NP_001002294" sequenceVersion="1" change="p.Glu65fs">
            <Expression>NP_001002294.1:p.Glu65fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001319173.2" sequenceAccession="NM_001319173" sequenceVersion="2" change="c.132del">
            <Expression>NM_001319173.2:c.132del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001306102.1" sequenceAccession="NP_001306102" sequenceVersion="1" change="p.Glu45fs">
            <Expression>NP_001306102.1:p.Glu45fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006894.4" sequenceAccession="NM_006894" sequenceVersion="4" change="c.192delA">
            <Expression>NM_006894.4:c.192delA</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_008825.4" sequenceAccession="NP_008825" sequenceVersion="4" change="p.Glu65Argfs">
            <Expression>NP_008825.4:p.Glu65Argfs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006894.6" sequenceAccession="NM_006894" sequenceVersion="6" change="c.192del">
            <Expression>NM_006894.6:c.192del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_008825.4" sequenceAccession="NP_008825" sequenceVersion="4" change="p.Glu65fs">
            <Expression>NP_008825.4:p.Glu65fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001319174.2" sequenceAccession="NM_001319174" sequenceVersion="2" change="c.133-3831del">
            <Expression>NM_001319174.2:c.133-3831del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="136132.0014" DB="OMIM" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001002294.3(FMO3):c.192del (p.Glu65fs) AND Trimethylaminuria" Accession="RCV000017710" Version="28">
        <ClassifiedConditionList TraitSetID="5286">
          <ClassifiedCondition DB="MedGen" ID="C0342739">Trimethylaminuria</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2003-08-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2003-08-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2015-08-15" MostRecentSubmission="2015-08-15">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">12893987</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="5286" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3918" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Fish malodor syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Stale fish syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">TMAuria</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">FISH-ODOR SYNDROME</ElementValue>
                <XRef Type="MIM" ID="602079" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Trimethylaminuria</ElementValue>
                <XRef ID="Trimethylaminuria/7223" DB="Genetic Alliance" />
                <XRef ID="HP:0003614" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0011182" DB="MONDO" />
                <XRef ID="237959005" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">TMAU</ElementValue>
                <XRef Type="MIM" ID="602079" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000505067" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000518973" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520120" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6447" />
                <XRef ID="6447" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Primary trimethylaminuria is characterized by a fishy odor resembling that of rotten or decaying fish that results from excess excretion of trimethylamine in the urine, breath, sweat, and reproductive fluids. No physical symptoms are associated with trimethylaminuria. Affected individuals appear normal and healthy; however, the unpleasant odor often results in social and psychological problems. Symptoms are usually present from birth and may worsen during puberty. In females, symptoms are more severe just before and during menstruation, after taking oral contraceptives, and around the time of menopause.</Attribute>
                <XRef ID="NBK1103" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301282</ID>
                <ID Source="BookShelf">NBK1103</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="PubMed">22126753</ID>
              </Citation>
              <XRef ID="C0342739" DB="MedGen" />
              <XRef ID="MONDO:0011182" DB="MONDO" />
              <XRef Type="MIM" ID="602079" DB="OMIM" />
              <XRef Type="primary" ID="HP:0003614" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="37987" SubmissionDate="2015-08-12" DateLastUpdated="2015-08-15" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="136132.0014_TRIMETHYLAMINURIA" title="FMO3, 1-BP DEL, 191A_TRIMETHYLAMINURIA" />
        <ClinVarAccession Accession="SCV000037987" DateUpdated="2015-08-15" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2003-08-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In an individual with trimethylaminuria (TMAU; 602079), Zhang et al. (2003) identified compound heterozygosity for 2 mutations in the FMO3 gene: a P153L change (136132.0004) and a 1-bp deletion (191delA) in exon 3 at codon 64. The deletion resulted in a frameshift and premature termination of the gene immediately after codon 65. Family pedigree analysis revealed that the 2 mutations were carried on different alleles in this individual. Both mutations abolished the catalytic activity of the enzyme, explaining the severe clinical expression of trimethylaminuria. The patient was examined at the age of 3 years, at which time he was found to have 61% unmetabolized trimethylamine in urine, compatible with severe trimethylaminuria.</Attribute>
              <Citation>
                <ID Source="PubMed">12893987</ID>
              </Citation>
              <XRef DB="OMIM" ID="602079" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FMO3" />
          </GeneList>
          <Name>FMO3, 1-BP DEL, 191A</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 191A</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="136132.0014" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">TRIMETHYLAMINURIA</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="37987" TraitType="Disease" MappingType="Name" MappingValue="TRIMETHYLAMINURIA" MappingRef="Preferred">
        <MedGen CUI="C0342739" Name="Trimethylaminuria" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

